Cancers of unknown primary origin: current perspectives and future therapeutic strategies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancers of unknown primary origin: current perspectives and future therapeutic strategies ; volume:10 ; number:1 ; day:24 ; month:1 ; year:2012 ; pages:1-11 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (24.1.2012), 1-11, 12.2012
- Urheber
-
Stella, Giulia Maria
- Beteiligte Personen und Organisationen
-
Senetta, Rebecca
Cassenti, Adele
Ronco, Margherita
Cassoni, Paola
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-12
- URN
-
urn:nbn:de:1111-2016041440842
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stella, Giulia Maria
- Senetta, Rebecca
- Cassenti, Adele
- Ronco, Margherita
- Cassoni, Paola
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary
Fever of unknown origin (FUO) revised
Human brucellosis and fever of unknown origin
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
Emerging therapeutic agents for genitourinary cancers
Neonatal jitteriness of unknown origin and circulating catecholamines
Correction: Human brucellosis and fever of unknown origin
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
Specific delivery of therapeutic agents against cancers
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary
Fever of unknown origin (FUO) revised
Human brucellosis and fever of unknown origin
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
Emerging therapeutic agents for genitourinary cancers
Neonatal jitteriness of unknown origin and circulating catecholamines
Correction: Human brucellosis and fever of unknown origin
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
Specific delivery of therapeutic agents against cancers
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary
Fever of unknown origin (FUO) revised
Human brucellosis and fever of unknown origin
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
Emerging therapeutic agents for genitourinary cancers
Neonatal jitteriness of unknown origin and circulating catecholamines
Correction: Human brucellosis and fever of unknown origin
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)